Portal de investigação
Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?
Autores da FMUP
Participantes de fora da FMUP
- Neves J.S.
- Zannad F.
- Butler J.
- Packer M.
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1558-3597, 0735-1097
- Tipo:
- Article
- Páginas:
- 1119-1122
- Link para outro recurso:
- www.scopus.com
Journal of the American College of Cardiology Elsevier USA
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- Clinical Trials as Topic; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptide-1 Receptor Agonists; Heart Failure; Humans; Stroke Volume; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; dapagliflozin; dipeptidyl carboxypeptidase inhibitor; empagliflozin; exendin 4; glucagon like peptide 1 receptor agonist; liraglutide; mineralocorticoid antagonist; sacubitril plus valsartan; semaglutide; sodium glucose cotransporter 2 inhibitor; glucagon like peptide 1 receptor; glucagon like peptide 1 receptor agonist; all cause mortality; Article; atherosclerosis; cardiovascular disease; cardiovascular mortality; coronary artery disease; diabetes mellitus; heart failure; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; heart infarction; heart left ventricle ejection fraction; heart left ventricle function; hospitalization; human; incidence; ischemic stroke; non insulin dependent diabetes mellitus; obesity; clinical trial (topic
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Citar a publicação
Neves JS,Zannad F,Butler J,Packer M,Ferreira JP. Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?. J. Am. Coll. Cardiol. 2024. 84. (12):p. 1119-1122. IF:24,000. (1).
